Publication
TLD-1, a novel liposomal doxorubicin, in patients with advanced solid tumors: Dose escalation and expansion part of a multicenter open-label phase I trial (SAKK 65/16).
Journal Paper/Review - Feb 2, 2024
Colombo Ilaria, Koster Kira-Lee, Holer Lisa, Haefliger Simon, Rabaglio-Poretti Manuela, Bastian Sara, Schwitter Michael, Eckhardt Katrin, Hayoz Stefanie, Mc Laughlin Anna M, Kloft Charlotte, Klose Marian, Halbherr Stefan, Baumgartner Christian, Sessa Cristiana, Stathis Anastasios, Hess Dagmar, Jörger Markus
Colombo, Ilaria
1
0
Koster, Kira-Lee
Medizinische Onkologie und Hämatologie · Dept. I
13
0
Holer, Lisa
1
0
Haefliger, Simon
2
0
Rabaglio-Poretti, Manuela
3
0
Bastian, Sara
5
2
Schwitter, Michael
3
0
Eckhardt, Katrin
3
0
Hayoz, Stefanie
22
0
Mc Laughlin, Anna M
1
0
Kloft, Charlotte
11
0
Klose, Marian
Halbherr, Stefan
Baumgartner, Christian
Sessa, Cristiana
12
0
Stathis, Anastasios
8
0
Hess, Dagmar
Medizinische Onkologie und Hämatologie · Dept. I
29
18
Jörger, Markus
chief of serviceMedizinische Onkologie und Hämatologie · Dept. I
189
48